XW0134CIntroduction of Elamipretide into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 12

New Technology›Anatomical Regions›Introduction
ICD-10-PCS XW0134C
CMS Source: FY 2027 ICD-10-PCS dataset. Effective Oct 1, 2026 – Sep 30, 2027.FacebookXLinkedInPrint

XW0134C is a billable ICD-10-PCS procedure code for Introduction of Elamipretide into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 12. It is valid on HIPAA claims for fiscal year 2027 (October 1, 2026 through September 30, 2027). The root operation Introduction involves putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products. The Alphabetic Index lists this code under Elamipretide.

Code Identity

ICD-10-PCS Code
XW0134C
Billable Status
Yes — Valid for Submission
Code Describes
Introduction of Elamipretide into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 12
Short Description
Introduce Elamipretide in Subcu, Perc, New Tech 12
Parent Code
XW0

PCS Table Breakdown

Each ICD-10-PCS code is built from seven characters, each an axis of the procedure. Hover or tap the icons for the official CMS definitions.

PositionDesignationValueMeaning
1SectionXNew Technology
2Body SystemWAnatomical Regions
3Operation0Introduction
4BodyPart1Subcutaneous Tissue
5Approach3Percutaneous
6Device/Substance/Technology4Elamipretide
7QualifierCNew Technology Group 12

In the ICD-10-PCS Alphabetic Index

The FY 2027 ICD-10-PCS Alphabetic Index refers to XW0134C as Elamipretide. These index entries lead to this code:

Elamipretide
Direct entry for this code
New Technology, Elamipretide
Direct entry for this code
Iloprost
Leads to this code's table
FORZINITY(tm)
Anatomy or device term that leads here
Sarilumab
Leads to this code's table
Posoleucel
Leads to this code's table
Rezafungin
Leads to this code's table
Treosulfan
Leads to this code's table
Baricitinib
Leads to this code's table
Sabizabulin
Leads to this code's table
Tocilizumab
Leads to this code's table
Caplacizumab
Leads to this code's table
COVID-19 Vaccine
Leads to this code's table
Inebilizumab-cdon
Leads to this code's table
Sulbactam-Durlobactam
Leads to this code's table

To code elamipretide, open the FY 2027 ICD-10-PCS Alphabetic Index at Elamipretide. The entry lists XW0134C directly as a complete, billable code.

Browse the full ICD-10-PCS Alphabetic Index →

Code History

FY 2027New code, effective October 1, 2026.
Replaces previously assigned code(s):
  • 3E013GC — Introduction of Oth Therap Subst into Subcu, Perc Approach

Similar Procedure Codes

Questions About XW0134C

Is XW0134C a billable code?

Yes. This is a complete seven-character ICD-10-PCS code, specific enough to report Introduction of Elamipretide into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 12 on inpatient claims from October 1, 2026 through September 30, 2027.

What is the ICD-10-PCS code for elamipretide?

The ICD-10-PCS Alphabetic Index lists Elamipretide under code XW0134C, Introduction of Elamipretide into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 12, billable on inpatient claims in fiscal year 2027.

What do the characters in XW0134C mean?

The code breaks down character by character: the 1st character X is the Section (New Technology); the 2nd character W is the Body System (Anatomical Regions); the 3rd character 0 is the Operation (Introduction); the 4th character 1 is the BodyPart (Subcutaneous Tissue); the 5th character 3 is the Approach (Percutaneous); the 6th character 4 is the Device/Substance/Technology (Elamipretide); the 7th character C is the Qualifier (New Technology Group 12).